
Research & Development
CSL Behring Research & Development
The following describes the research interests of a global organisation and includes information on products that are not yet licensed or available in the UK.
CSL Behring is a global specialty biopharmaceutical company which aims to identify, develop and commercialise important, new, biotherapeutic products that help to prevent or treat serious medical conditions. The company is committed to investing in its future product portfolio and capabilities in the areas of immunoglobulins, specialty products, haemophilia products and possible breakthrough medicines.
CSL Behring also has a strong commitment to funding research and development of protein-based medicines for unmet medical needs, which underpins its continued growth.
CSL Behring operates as one integrated global research and development organisation. We assemble co-ordinated global project teams, drawing together staff from different countries depending on their expertise. These teams rely on a project management framework that facilitates collaboration across national and cultural boundaries.
R&D Partnerships
To complement in-house expertise, we also draw on strategic partnerships with academic institutions and other organisations globally. These collaborative partnerships support a range of effective research programmes, including both basic and applied research in plasma derived and recombinant protein-based product development.
-
US $1.16 billion
was invested in R&D in 2021/22 across our businesses
-
US $4.6 billion
in R&D investments in the last 5 years
-
>2,000
research & development employees
Global R&D Network
CSL Behring is a global specialty biotech with a strong commitment to funding research and development of medicines to support its continued growth. We operate as one integrated global research and development organisation that assembles coordinated global project teams, drawing together staff from different countries depending on their expertise. Our teams rely on a project management framework that facilities collaboration across national and cultural boundaries.
Australia
PARKVILLE, VIC
CSL Limited
Global Corporate HQ
R&D and Manufacturing
BROADMEADOWS, VIC
CSL Behring
R&D and Manufacturing
NORTH MELBOURNE, VIC
Bio21 Global Research and Translational Medicine Hub
Germany
MARBURG
CSL Behring
R&D and Manufacturing
United States
KING OF PRUSSIA, PA
CSL Behring
Head Office and R&D
KANKAKEE, IL
CSL Behring
R&D and Manufacturing
PASADENA, CA
Calimmune
R&D
Switzerland
BERN
CSL Behring
R&D and Manufacturing
Japan
TOKYO
CSL Behring
R&D
China
WUHAN
Ruide
R&D and Manufacturing